Redalpine Venture Partners
Redalpine is a prominent venture capital firm investing in innovative companies across various sectors, particularly focusing on technology and life sciences. With over CHF 1 billion in assets under management, Redalpine is recognized as one of the most experienced VC funds in Europe.
-
Type of investor
VC -
Based in
Zürich -
Number of investments
10+ -
Industry
biotech, consumer products, healthcare IT, ICT, Impact, Interdisciplinary, medtechVisit website of
Redalpine Venture Partners
Related News
01.05.2025 11:00
Aktiia secures $42 million Series B funding and rebrands to Hilo
14.11.2024 13:20
CHF 4 million seed funding for Geneva-based orthodontic startup
17.10.2024 17:00
CHF 2.8 million to improve eCommerce recommendations
17.05.2024 11:00
Swiss venture capital firms under new leadership
07.05.2024 08:19
Memo Therapeutics raises additional CHF20 million
27.02.2024 15:02
Aktiia banks CHF 27 million to mitigate hypertension worldwide
15.02.2024 17:00
Dropz sammelt frisches Geld für Produkterweiterung ein
02.11.2023 08:27
Memo Therapeutics Raises CHF 25 Million Series C Financing
23.03.2023 16:28
Lunaphore raises CHF40 million
20.03.2023 14:20
Zürcher Privatbank ermöglicht Kunden Risikokapital-Investments
06.03.2023 17:12
Relai's Bitcoin-Only Platform Draws $4.5 Million Investment
13.10.2022 10:36
16 Millionen Franken für Auto-Abo-Pionier Carvolution
04.10.2022 16:33
Araris Biotech Closes $24 Million Financing Round
07.06.2022 14:00
ImmunOs Therapeutics raises $74 Million to fund clinical trials
27.05.2022 13:00
More than € 2.1 million for bitcoin app
09.11.2021 09:30
Luya Foods closes Seed financing round
02.11.2021 12:30
Aktiia closes $17.5 million Series A financing round
18.06.2021 08:23
Bitcoin Investment App Relai Raises CHF 2.5 Million
10.06.2020 11:00
Additional capital for TOLREMO therapeutics
02.04.2020 09:43
«Wir ziehen unsere Strategie durch»
24.03.2020 10:25
Aktiia raises CHF 6 million to enter the market
06.02.2020 11:46
Lunaphore receives CHF 23M Series C financing
10.12.2019 11:42
ImmunOs Therapeutics AG raises CHF 15M in Series A Financing
21.11.2019 12:09
11,25 Millionen Franken für Carvolution
16.10.2019 17:44
EraCal closes oversubscribed seed round
18.09.2019 08:24
Versantis obtain funds to fuel clinical trials
20.08.2019 09:00
Araris obtains CHF 2.5 million after only six months of existence
26.04.2019 14:00
RosieReality closes seed round
19.02.2019 12:10
Series-A Runde für Auto-Abo Startup
24.09.2018 11:04
TOLREMO raises CHF9 million series A financing round
30.08.2018 09:03
Lunaphore closes CHF 5.3M financing round
23.07.2018 16:55
Pre-seed funds for Rosie the Robot
05.07.2018 11:41
Mobiliar kauft Bexio
09.05.2018 14:12
CHF 5 million for Memo Therapeutics
04.10.2017 10:51
Lunaphore closes a CHF 6M financing round
29.03.2017 08:47
Versantis Raises CHF 4.4 Million in Series A Financing
08.12.2016 10:09
1.3 Millionen für Codecheck
15.11.2016 15:30
Ava closes $10M Series A Round
12.01.2016 12:25
Biognosys raises new funds for US expansion
26.10.2015 08:50
Knip Closes $15,7 Million Series B Funding Round
22.07.2015 11:24
Memo Therapeutics raises CHF 2.3 million
15.11.2011 14:16
Kapital für Wachstumsunternehmen
19.09.2011 14:21
Malcisbo closes seed financing round
The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". 
